GORKA
ORIVE ARROYO
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (4)
2022
-
Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients
Frontiers in Immunology, Vol. 13
-
Saliva is a Good Candidate to be the New Gold-Standard Sample for Neurodegenerative Diseases
Journal of Alzheimer's Disease, Vol. 87, Núm. 4, pp. 1497-1501
2021
-
Cost-effectiveness analysis of text messaging to support health advice for smoking cessation
Cost Effectiveness and Resource Allocation, Vol. 19, Núm. 1
2017
-
Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 8, pp. 131-138